Novo Nordisk A/S (FRA:NOVA)

Novo Nordisk Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 29, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	205,049	371,731	417,564	284,852	225,277	132,551
Market Cap Growth	-62.24%	-10.98%	46.59%	26.45%	69.96%	8.92%
Enterprise Value	215,805	369,330	414,739	283,305	222,367	129,679
Last Close Price	47.10	81.56	90.46	60.97	46.26	27.05
PE Ratio	13.77	27.45	37.19	38.16	35.07	23.41
PS Ratio	4.90	9.55	13.40	11.97	11.90	7.77
PB Ratio	9.10	19.32	29.21	25.38	23.68	15.58
P/TBV Ratio	25.41	85.58	67.43	65.10	60.74	23.12
P/FCF Ratio	23.45	37.56	37.45	31.75	34.42	21.39
P/OCF Ratio	12.59	22.92	28.58	26.86	30.45	18.99
EV/Sales Ratio	5.17	9.49	13.31	11.91	11.74	7.60
EV/EBITDA Ratio	10.03	18.78	27.97	25.98	25.93	16.48
EV/EBIT Ratio	10.84	19.69	29.53	27.87	27.92	17.83
EV/FCF Ratio	24.68	37.32	37.20	31.57	33.97	20.93
Debt / Equity Ratio	0.59	0.72	0.25	0.31	0.38	0.16
Debt / EBITDA Ratio	0.62	0.69	0.24	0.31	0.41	0.17
Debt / FCF Ratio	1.52	1.39	0.33	0.39	0.55	0.23
Asset Turnover	0.73	0.74	0.84	0.81	0.83	0.94
Inventory Turnover	1.20	1.20	1.26	1.29	1.24	1.16
Quick Ratio	0.51	0.52	0.62	0.67	0.65	0.64
Current Ratio	0.78	0.74	0.82	0.90	0.86	0.94
Return on Equity (ROE)	79.17%	80.77%	88.07%	72.00%	71.24%	69.70%
Return on Assets (ROA)	21.82%	22.41%	23.55%	21.69%	21.81%	25.01%
Return on Capital (ROIC)	42.52%	46.03%	53.89%	45.74%	43.27%	49.84%
Return on Capital Employed (ROCE)	54.10%	56.30%	72.30%	62.80%	62.30%	72.50%
Earnings Yield	7.26%	3.64%	2.69%	2.62%	2.85%	4.27%
FCF Yield	4.26%	2.66%	2.67%	3.15%	2.90%	4.67%
Dividend Yield	2.35%	1.87%	1.39%	1.37%	1.51%	2.26%
Payout Ratio	45.63%	43.71%	37.96%	45.57%	45.05%	47.75%
Buyback Yield / Dilution	0.57%	0.71%	1.10%	1.34%	1.58%	1.63%
Total Shareholder Return	2.92%	2.58%	2.49%	2.70%	3.09%	3.89%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.